Literature DB >> 18382181

Cutaneous drug eruptions by current antiepileptics: case reports and alternative treatment options.

Sevki Sahin1, Asuman Comert, Ozlem Akin, Sunay Ayalp, Sibel Karsidag.   

Abstract

Serious cutaneous drug eruptions due to antiepileptics have been defined for many drugs like carbamazepine, diphenylhydantoin, phenytoin and valproate. In recent years, adverse cutaneous reactions due to the current antiepileptic drugs have also been reported. In this paper, two cases are presented: a 48-year-old female receiving gabapentin for postherpetic neuralgia who developed leukocytoclastic vasculitis after 8 weeks and a 23-year-old male receiving lamotrigine for epileptic seizures who developed toxic epidermal necrolysis (TEN) in 15 days. Alternative therapy approaches with practical suggestions are also discussed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18382181     DOI: 10.1097/WNF.0b013e31806ad6cb

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  5 in total

1.  Multidrug-related leukocytoclastic vasculitis raising suspicion of sexual homicide-things are not always what they seem.

Authors:  Lucia Tattoli; Klaus Krocker; Julia Sautter; Michael Tsokos
Journal:  Int J Legal Med       Date:  2015-05-10       Impact factor: 2.686

2.  Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury.

Authors:  Kristen E Jones; Ava M Puccio; Kathy J Harshman; Bonnie Falcione; Neal Benedict; Brian T Jankowitz; Martina Stippler; Michael Fischer; Erin K Sauber-Schatz; Anthony Fabio; Joseph M Darby; David O Okonkwo
Journal:  Neurosurg Focus       Date:  2008-10       Impact factor: 4.047

Review 3.  Phenytoin versus Leviteracetam for seizure prophylaxis after brain injury - a meta analysis.

Authors:  Syed Nabeel Zafar; Abdul Ahad Khan; Asfar Ayaz Ghauri; Muhammad Shahzad Shamim
Journal:  BMC Neurol       Date:  2012-05-29       Impact factor: 2.474

Review 4.  Cutaneous Adverse Effects of Neurologic Medications.

Authors:  Eman Bahrani; Chloe E Nunneley; Sylvia Hsu; Joseph S Kass
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 6.497

Review 5.  Role of intravenous levetiracetam in seizure prophylaxis of severe traumatic brain injury patients.

Authors:  Batool F Kirmani; Diana Mungall; Geoffrey Ling
Journal:  Front Neurol       Date:  2013-11-01       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.